Skip to content
★ Sign in to follow
DC

David Cunningham

Board Director
Director
Immucell Corp
Total declarations
22
Company
1
▲ Purchases (18 ops.)
€58k
▼ Sales (0 ops.)
—

Latest filing published 14 Jun 2022 for Immucell CORP, €7,681.

Filing timeline

BuySale
David Cunningham

Insider track record

Disclosed buys
18
Disclosed sells
0
Signal history

Closed purchases

Market purchases
18
Positive at T+90
88%
Median T+90
+15.5%

Based on 17 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 14 Jun 2022 · 1609 days ago · €7,681
    -32.1%
    Entry US$8.12 · Close at T+365 US$5.51
  • Filed 12 Mar 2020 · 2433 days ago · €7,104
    +162.5%
    Entry US$4.00 · Close at T+365 US$10.50
  • Filed 22 Aug 2016 · 3731 days ago · €19k
    -15.7%
    Entry US$7.25 · Close at T+365 US$6.11
  • Filed 01 Feb 2016 · 3934 days ago · €9,140
    -4.2%
    Entry US$6.15 · Close at T+365 US$5.89
  • Filed 16 May 2014 · 4560 days ago · €4,276
    +101.8%
    Entry US$3.98 · Close at T+365 US$8.03

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

David Cunningham: trading record in brief

This profile gathers the share dealings of David Cunningham in Immucell Corp, where the filings describe the role as board member. Between 14 August 2013 and 13 June 2022, the trades on record add up to 22 filings.

On the market, this insider has only ever bought: 18 purchases, €58k in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 2 option exercises. So far in 2022, the count stands at 1 purchase and no sales.

In size, the median ticket on the buying side is €908. 2 out of 4 purchases came within 30 days of a purchase by at least one other insider of the same company. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. After 17 purchases with a full 90-day history, the hit rate stands at 88% and the median 90-day move at +15.5%. They describe history only and say nothing certain about the share price ahead.

Most recently, on 14 June 2022, the filings show an open-market purchase worth €7,681 in Immucell Corp. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to David Cunningham

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations21 total
  • ▲
    DirectorExecutivesImmucell Corp
    8,000 USD19SEC
    1,000 shares@ US$8.00100.0% of flowCommon stock $0.10 per value per shareSEC:0001213900-22-032625:0
    Canonical exit: 11 Sept 2022 (T+90)
  • ▲
    DirectorExecutivesImmucell Corp
    8,000 USD26SEC
    2,000 shares@ US$4.0029.7% of flowCommon Stock, par value $0.10 per shareSEC:0001213900-20-006134:0
    Canonical exit: 10 Jun 2020 (T+90)
  • ●
    DirectorExecutivesImmucell Corp
    6,222 USD13SEC
    930 shares@ US$6.6918.6% of flowCommon Stock, par value $0.10 per shareSEC:0001213900-18-011272:0
  • ●
    DirectorExecutivesImmucell Corp
    57,425 USD18SEC
    7,334 shares@ US$7.8329.1% of flowCommon Stock, par value $0.10 per shareSEC:0001547522-16-000302:0
  • ◇
    DirectorExecutivesImmucell Corp
    57,500 USD18SEC
    10,000 shares@ US$5.7529.1% of flowCommon Stock, par value $0.10 per shareSEC:0001547522-16-000302:1
  • ▲
    DirectorExecutivesImmucell Corp
    21,420 USD14SEC
    3,000 shares@ US$7.1410.7% of flowCommon Stock, par value $0.10 per shareSEC:0001547522-16-000287:0
    Canonical exit: 20 Nov 2016 (T+90)
  • ◇
    DirectorExecutivesImmucell Corp
    28,750 USD14SEC
    5,000 shares@ US$5.7514.4% of flowCommon Stock, par value $0.10 per shareSEC:0001547522-16-000285:0
  • ▲
    DirectorExecutivesImmucell Corp
    9,996 USD34SEC
    1,904 shares@ US$5.2554.3% of flowCommon Stock, par value $0.10 per shareSEC:0001547522-16-000202:0
    Canonical exit: 28 Apr 2016 (T+90)
  • ▲
    DirectorExecutivesImmucell Corp
    5,865 USD0SEC
    1,500 shares@ US$3.91Common Stock, par value $0.10 per shareSEC:0001144204-14-031564:0
    Canonical exit: 13 Aug 2014 (T+90)
  • ▲
    DirectorExecutivesImmucell Corp
    583 USD0SEC
    162 shares@ US$3.60Common Stock, par value $0.10 per shareSEC:0001144204-13-046545:0
    Canonical exit: 12 Nov 2013 (T+90)
  • ▲
    DirectorExecutivesImmucell Corp
    137 USD0SEC
    38 shares@ US$3.60Common Stock, par value $0.10 per shareSEC:0001144204-13-046545:1
    Canonical exit: 12 Nov 2013 (T+90)
  • ▲
    DirectorExecutivesImmucell Corp
    360 USD0SEC
    100 shares@ US$3.60Common Stock, par value $0.10 per shareSEC:0001144204-13-046545:2
    Canonical exit: 12 Nov 2013 (T+90)
  • ▲
    DirectorExecutivesImmucell Corp
    226 USD0SEC
    62 shares@ US$3.65Common Stock, par value $0.10 per shareSEC:0001144204-13-046545:3
    Canonical exit: 12 Nov 2013 (T+90)
  • ▲
    DirectorExecutivesImmucell Corp
    1,825 USD0SEC
    500 shares@ US$3.65Common Stock, par value $0.10 per shareSEC:0001144204-13-046545:4
    Canonical exit: 12 Nov 2013 (T+90)
  • ▲
    DirectorExecutivesImmucell Corp
    365 USD0SEC
    100 shares@ US$3.65Common Stock, par value $0.10 per shareSEC:0001144204-13-046545:5
    Canonical exit: 12 Nov 2013 (T+90)
  • ▲
    DirectorExecutivesImmucell Corp
    139 USD0SEC
    38 shares@ US$3.65Common Stock, par value $0.10 per shareSEC:0001144204-13-046545:6
    Canonical exit: 12 Nov 2013 (T+90)
  • ▲
    DirectorExecutivesImmucell Corp
    3,700 USD0SEC
    1,000 shares@ US$3.70Common Stock, par value $0.10 per shareSEC:0001144204-13-046545:7
    Canonical exit: 13 Nov 2013 (T+90)
  • ▲
    DirectorExecutivesImmucell Corp
    133 USD0SEC
    36 shares@ US$3.70Common Stock, par value $0.10 per shareSEC:0001144204-13-046545:9
    Canonical exit: 14 Nov 2013 (T+90)
  • ▲
    DirectorExecutivesImmucell Corp
    369 USD0SEC
    100 shares@ US$3.69Common Stock, par value $0.10 per shareSEC:0001144204-13-046545:10
    Canonical exit: 14 Nov 2013 (T+90)
  • ▲
    DirectorExecutivesImmucell Corp
    370 USD0SEC
    100 shares@ US$3.70Common Stock, par value $0.10 per shareSEC:0001144204-13-046545:11
    Canonical exit: 14 Nov 2013 (T+90)
  • ▲
    DirectorExecutivesImmucell Corp
    2,827 USD0SEC
    764 shares@ US$3.70Common Stock, par value $0.10 per shareSEC:0001144204-13-046545:12
    Canonical exit: 14 Nov 2013 (T+90)

21 of 21 declarations